NRSN
Neurosense Therapeutics
$0.59
−$0.01 (−2.49%)Jul 27, 2026
Key metrics
The numbers that frame NRSN today
- Market cap
- $19.11M
- P/E (TTM)
- -1.7
- EV / FCF
- -2.5
- ROIC
- 936.1%
- Div yield
- 0%
- 52wk Low
- $0.58
- 52wk High
- $2.09
Growth
Revenue and earnings trend for NRSN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NRSN
Is Neurosense Therapeutics a good buy?
No. Neurosense Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. We think Neurosense Therapeutics is selling at a very high price.
What is the market capitalization of NRSN?
Neurosense Therapeutics's market capitalization is $19.11M.
What is the P/E ratio for NRSN stock?
Neurosense Therapeutics's current P/E ratio is -1.7.
What is the 52-week high for NRSN stock?
The 52-week high for Neurosense Therapeutics is $2.09. The current close of $0.59 is 71.9% below that high.
What is the 52-week low for NRSN stock?
The 52-week low for Neurosense Therapeutics is $0.58. The current close of $0.59 is 1.2% above that low.
Does NRSN stock pay dividends?
Neurosense Therapeutics does not currently show a dividend per share in the company data.